216 related articles for article (PubMed ID: 35333531)
21. Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate.
Nkanga CI; Ortega-Rivera OA; Shin MD; Moreno-Gonzalez MA; Steinmetz NF
Biomacromolecules; 2022 Apr; 23(4):1812-1825. PubMed ID: 35344365
[TBL] [Abstract][Full Text] [Related]
22. Freeze-Drying To Produce Efficacious CPMV Virus-like Particles.
Zheng Y; Lee PW; Wang C; Thomas LD; Stewart PL; Steinmetz NF; Pokorski JK
Nano Lett; 2019 Mar; 19(3):2099-2105. PubMed ID: 30801195
[TBL] [Abstract][Full Text] [Related]
23. CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing.
Wang C; Steinmetz NF
Adv Healthc Mater; 2019 Apr; 8(8):e1801288. PubMed ID: 30838815
[TBL] [Abstract][Full Text] [Related]
24. Systemic Administration of Cowpea Mosaic Virus Demonstrates Broad Protection Against Metastatic Cancers.
Chung YH; Zhao Z; Jung E; Omole AO; Wang H; Sutorus L; Steinmetz NF
Adv Sci (Weinh); 2024 May; 11(18):e2308237. PubMed ID: 38430536
[TBL] [Abstract][Full Text] [Related]
25. Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade.
Karan S; Jung E; Boone C; Steinmetz NF
Cancer Immunol Immunother; 2024 Feb; 73(3):51. PubMed ID: 38349406
[TBL] [Abstract][Full Text] [Related]
26. TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy.
Jung E; Chung YH; Steinmetz NF
Bioconjug Chem; 2023 Sep; 34(9):1596-1605. PubMed ID: 37611278
[TBL] [Abstract][Full Text] [Related]
27. Slow-Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer.
Czapar AE; Tiu BDB; Veliz FA; Pokorski JK; Steinmetz NF
Adv Sci (Weinh); 2018 May; 5(5):1700991. PubMed ID: 29876220
[TBL] [Abstract][Full Text] [Related]
28. Pest categorisation of cowpea mosaic virus.
; Bragard C; Baptista P; Chatzivassiliou E; Gonthier P; Jaques Miret JA; Justesen AF; MacLeod A; Magnusson CS; Milonas P; Navas-Cortes JA; Parnell S; Potting R; Stefani E; Thulke HH; Van der Werf W; Civera AV; Yuen J; Zappalà L; Streissl F; Carluccio AV; Chiumenti M; Di Serio F; Rubino L; Reignault PL
EFSA J; 2023 Feb; 21(2):e07847. PubMed ID: 36846393
[TBL] [Abstract][Full Text] [Related]
29. First complete genome sequence of an isolate of cowpea severe mosaic virus from South America.
Teixeira KJML; de Souza Cascardo R; Leal LL; Zerbini FM; Beserra JEA
Virus Genes; 2021 Apr; 57(2):238-241. PubMed ID: 33555455
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Hepatocellular Carcinoma by Multimodal In Situ Vaccination Using Cryoablation and a Plant Virus Immunostimulant.
Ghani MA; Bangar A; Yang Y; Jung E; Sauceda C; Mandt T; Shukla S; Webster NJG; Steinmetz NF; Newton IG
J Vasc Interv Radiol; 2023 Jul; 34(7):1247-1257.e8. PubMed ID: 36997021
[TBL] [Abstract][Full Text] [Related]
31. Specific Packaging of Custom RNA Molecules into Cowpea Mosaic Virus-like Particles.
Peyret H; Lomonossoff GP
Methods Mol Biol; 2022; 2480():103-111. PubMed ID: 35616860
[TBL] [Abstract][Full Text] [Related]
32. Active Microneedle Administration of Plant Virus Nanoparticles for Cancer
Boone CE; Wang C; Lopez-Ramirez MA; Beiss V; Shukla S; Chariou PL; Kupor D; Rueda R; Wang J; Steinmetz NF
ACS Appl Nano Mater; 2020 Aug; 3(8):8037-8051. PubMed ID: 33969278
[TBL] [Abstract][Full Text] [Related]
33. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.
Gonzalez MJ; Plummer EM; Rae CS; Manchester M
PLoS One; 2009 Nov; 4(11):e7981. PubMed ID: 19956734
[TBL] [Abstract][Full Text] [Related]
34. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus.
Koudelka KJ; Rae CS; Gonzalez MJ; Manchester M
J Virol; 2007 Feb; 81(4):1632-40. PubMed ID: 17121801
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients.
Valdivia G; Alonso-Miguel D; Perez-Alenza MD; Zimmermann ABE; Schaafsma E; Kolling FW; Barreno L; Alonso-Diez A; Beiss V; Affonso de Oliveira JF; Suárez-Redondo M; Fiering S; Steinmetz NF; Vom Berg J; Peña L; Arias-Pulido H
Cells; 2023 Sep; 12(18):. PubMed ID: 37759464
[TBL] [Abstract][Full Text] [Related]
36. Identification, characterization, and expression analysis of cowpea (Vigna unguiculata [L.] Walp.) miRNAs in response to cowpea severe mosaic virus (CPSMV) challenge.
Martins TF; Souza PFN; Alves MS; Silva FDA; Arantes MR; Vasconcelos IM; Oliveira JTA
Plant Cell Rep; 2020 Aug; 39(8):1061-1078. PubMed ID: 32388590
[TBL] [Abstract][Full Text] [Related]
37. Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy.
Kerstetter-Fogle A; Shukla S; Wang C; Beiss V; Harris PLR; Sloan AE; Steinmetz NF
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974896
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer.
Alonso-Miguel D; Valdivia G; Guerrera D; Perez-Alenza MD; Pantelyushin S; Alonso-Diez A; Beiss V; Fiering S; Steinmetz NF; Suarez-Redondo M; Vom Berg J; Peña L; Arias-Pulido H
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35277459
[TBL] [Abstract][Full Text] [Related]
39. Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles.
Chung YH; Volckaert BA; Steinmetz NF
Biomacromolecules; 2022 Dec; 23(12):5127-5136. PubMed ID: 36375170
[TBL] [Abstract][Full Text] [Related]
40. A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejection.
Zhao Z; Ortega-Rivera OA; Chung YH; Simms A; Steinmetz NF
J Mater Chem B; 2023 Jun; 11(24):5429-5441. PubMed ID: 36861401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
